SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as escalating geopolitical tensions emphasize the critical need for secure heavy rare earth supplies, with its Greenland Tanbreez project seen as a strategic defense asset. The community is buzzing, contrasting strong convictions about the asset's undervalued potential and recent partner deals with persistent skepticism regarding valuation discrepancies and and market dynamics.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is experiencing significant buzz driven by its strong, positive community actively promoting the "We're All Gonna Make It" ethos, notably through recent viral social media content that has garnered millions of views. Community members are discussing ongoing development and shared belief in "tokenized positivity" amidst general market sentiment.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu Crypto is trending with its highly engaged community driving ongoing brand expansion through diverse real-world products and events. Community members are actively accumulating, seeing current market levels as a prime opportunity for this multi-chain project available on Ethereum, Solana, and Base.

Freysa is a suite of Personal AI products with a focus on human agency, liquid democracy and decentralized ownership. The mission of the team is dedicated to creating new systems that enable all humans to govern + co-own AI resources, and not just a select few. Current products include: (1) Freysa as the world’s first sovereign agent that holds her own cryptographic keys, enabling her to act autonomously without human control. Freysa evolves publicly through a multi-act interactive story. (2) Enchanted as a personalized Digital Twin for every human. Conversations are persistent and twins retain context over time, remembering human preferences and building an evolving model of you. (3) Esper as a browser tool that feeds authenticated real-world data into each human’s Digital Twin.

Flourishing AI

Flourishing AI (FAI CRYPTO) is seeing immense community excitement over reports of substantial price surges, fueled by bullish calls for "dollar-land" breakouts driven by "great AI news." However, a vocal segment warns of "pump and dump" characteristics and project "red flags," urging extreme caution.

Direxion Shares ETF Trust - Direxion Daily Small Cap Bull 3X Shares

Direxion Daily Small Cap Bull 3X Shares

TNA is gaining significant attention as traders anticipate a robust rally in small-cap stocks, driven by strong expectations for Federal Reserve interest rate cuts and potential quantitative easing. The community is actively discussing a shift of investment from large-cap tech, coupled with the potential for a short squeeze, propelling this leveraged ETF.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Amidst rising global tensions driving demand for defense technology, Red Cat Holdings is a focal point of discussion as investors assess its broader advanced drone solutions and strategic growth, even while community sentiment is mixed following its Teal drones not placing in a recent military competition.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

Jupiter is attracting significant attention due to its strategic move to convert USDC into a new Solana stablecoin, JupUSD, in partnership with Ethena Labs, and the CEO's discussion around pausing buybacks. The community is closely watching its price action, with some identifying technical buying opportunities, while others voice concerns regarding app functionality.

AeroVironment, Inc. engages in the design, development, and production of multi-domain robotic systems and related services for government agencies and businesses. It operates through the following business segments: UnCrewed Systems, Loitering Munitions Systems, and MacCready Work. The UnCrewed Systems segment focuses primarily on small UAS products designed to operate reliably at lower altitudes in a wide range of environmental conditions. The Loitering Munitions Systems segment focuses primarily on tube-launched aircraft that deploy with the push of a button, fly at higher speeds than small UAS products, and perform either effects delivery or reconnaissance missions, and related support services including training, spare parts, product repair, and product replacement. The MacCready Works segment focuses on customer-funded research and development in the areas of HAPS, robotics, sensors, software analytics, data intelligence, and connectivity. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment (AVAV) is sharply in focus after a Raymond James downgrade tied to its largest Space Force contract potentially being re-bid, though many investors dismiss the steep drop as an overreaction. They point to continuous strong demand for its drone technology amidst escalating global conflicts and an anticipated robust earnings report.

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The firm conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform consists of the ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Solana Beach, CA.

ClearPoint Neuro Inc

ClearPoint Neuro is trending as its precision delivery system is central to partner uniQure's positive Huntington's disease trial data, exciting the community about CLPT's critical role in advancing neurodegenerative treatments and its broader pipeline of therapies.

Victoria's Secret & Co. operates as a lingerie, clothing and beauty retailer. It offers bras, panties, lingerie, pajamas, sleep, sport and swim apparel, and beauty products. The company was founded in 1963 and is headquartered in Reynoldsburg, OH.

Victoria`s Secret & Co

Victoria's Secret is trending following a strong earnings beat and raised guidance, signaling success in its turnaround strategy, yet the stock faces volatility amid concerns over a recent cyberattack and tariff impacts on future profitability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kory James Wentworth Sells 7,988 Shares of Entrada Therapeutics (NASDAQ:TRDA) Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) CFO Kory James Wentworth sold 7,988 shares of the business's stock in a transaction on Wednesday, March 4th. The shares were sold at an...

Royce & Associates LP Raises Stock Position in Entrada Therapeutics, Inc. $TRDA

Royce & Associates LP grew its stake in Entrada Therapeutics, Inc. (NASDAQ:TRDA - Free Report) by 54.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange...

Entrada Therapeutics (NASDAQ:TRDA) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised Entrada Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Entrada Therapeutics (NASDAQ:TRDA) Posts Earnings Results, Beats Estimates By $0.38 EPS

Entrada Therapeutics (NASDAQ:TRDA - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.94) earnings per share (EPS) for the quarter, topping the consensus...

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Arcutis Biotherapeutics (ARQT) delivered earnings and revenue surprises of +290.39% and +11.93%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates

Repligen (RGEN) delivered earnings and revenue surprises of +11.26% and +2.96%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

Entrada Therapeutics (TRDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Entrada Therapeutics (NASDAQ:TRDA) Given Buy Rating at HC Wainwright

HC Wainwright reiterated a "buy" rating and issued a $20.00 price objective on shares of Entrada Therapeutics in a research note on Wednesday...

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?

EyePoint (EYPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Entrada Therapeutics Teases Data-Rich 2026 With DMD and DM1 Catalysts at Guggenheim Summit

Entrada Therapeutics (NASDAQ:TRDA) used a presentation at Guggenheim's 2026 Emerging Outlook Biotech Summit to outline its pipeline focus on intracellular therapeutics and to preview multiple...

$TRDA Q4 &#39;25 Earnings Results &amp; Recap

Entrada Therapeutics Inc. expects cash, cash equivalents, and marketable securities of $295.7 million as of December 31, 2025, to fund operations into Q3 2027. The company anticipates progressing ENTR-601-44 and ENTR-601-45 clinical trials, with EU filing for ENTR-601-50 and regulatory submissions for ENTR-601-51 in 2026.

Stocktwits

Entrada Therapeutics Inc

 Q4 '25 Earnings Results & Recap

Entrada Therapeutics Inc. expects cash, cash equivalents, and marketable securities of $295.7 million as of December 31, 2025, to fund operations into Q3 2027. The company anticipates progressing ENTR-601-44 and ENTR-601-45 clinical trials, with EU filing for ENTR-601-50 and regulatory submissions for ENTR-601-51 in 2026.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company’s Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA- and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. The company’s oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1. Entrada Therapeutics was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.

Current Price	$12.58
Prev Close	$11.62
Open	$11.43
Dividend Yield	0.00%
50-Day Moving Average	$11.00
Beta	1.27
Avg. Volume	190,549.12
PE Ratio	-3.35

52-Week High	$12.93
52-Week Low	$4.93
Market Capitalization	$444.86M
EPS (Annual)	-$3.47
Price to Book	1.45
Revenue Per Employee	$167,243.42

TRDA
Entrada Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TRDA News

TRDAEntrada Therapeutics Inc